Molecular dynamics study of the internal water molecules in vasopressin and oxytocin receptors

Protein and Peptide Letters

Volumn 16, Issue 4, 2009, Pages 342-350

  Ślusarz, Magdalena J ^a   Ślusarz, Rafałs ^a   Ciarkowski, Jerzy ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

GPCR; Internal water; Molecular dynamics; Protein hydration; Vasopressin and oxytocin receptors

Indexed keywords

LIGAND; OXYTOCIN; OXYTOCIN RECEPTOR; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR; WATER;

ARTICLE; BINDING SITE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; HYDROGEN BOND;

BINDING SITES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; OXYTOCIN; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; VASOPRESSINS; WATER;

EID: 65349166282     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609787848072     Document Type: Article

References (57)

1. Meyer, E. Internal water molecules and H-bonding in biological macromolecules: a review of structural features with functional implications. Prot. Sci., 1992, 1, 1543-1562.
2. Papoian, G.A.; Ulander, J.; Eastwood, M.P.; Luthey-Schulten, Z.; Wolynes, P.G. Water in protein structure prediction. Proc. Natl. Acad. Sci., 2004, 101, 3352-3357.
3. Papoian, G.A.; Ulander, J.; Wolynes, P.G. Role of water mediated interactions in protein-protein recognition landscapes. J. Am. Chem. Soc., 2003, 125, 9170-9178.
4. Ben-Naim, A. Molecular recognition-viewed through the eyes of the solvent. Biophys. Chem., 2002, 101-102, 309-319.
5. Ikura, T.; Urakubo, Y.; Nobutoshi, I. Water-mediated interaction at a protein-protein interface. Chem. Phys., 2004, 307, 111-119.
6. Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J., 1999, 18, 1723-1729.
7. Pierce, K.L.; Premont, R.T.; Lefkowitz, R. J. Seven Transmem-brane Spanning Receptors. Nature Rev. Mol. Cell Biol., 2002, 3, 639-650.
8. Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev., 2000, 21, 90-113.
9. Becker, O.M.; Shacham, S.; Marantz, Y.; Noiman, S. Modeling the 3D structure of GPCRs: advances and application to drug discovery. Curr. Opin. DrugDiscov. Devel., 2003, 6, 353-361.
10. Ballesteros, J.; Palczewski, K. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. DrugDiscov. Devel., 2001, 4, 561-574.
11. Barberis, C.; Mouillac, B.; Durroux, T. Structural bases of vaso-pressin/oxytocin receptor function. J. Endocrinol., 1998, 156, 223-229.
12. Zingg, H.H. Vasopressin and oxytocin receptors. Baillieres Clin. Endocrinol. Metab., 1996, 10, 75-96.
13. Thibonnier, M.; Berti-Mattera, L.N.; Dulin, N.; Conarty, D.M.; Mattera, R. Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors. Prog. Brain. Res., 1998, 119, 147-161.
14. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science, 2000, 289, 739-745.
15. Ballesteros, J.A.; Shi, L.; Javitch, J.A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol., 2001, 60, 1-19.
16. Mirzadegan, T.; Benko, G.; Filipek, S.; Palczewski, K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry, 42, 2003, 2759-2767.
17. Archer, E.; Maigret, B.; Escrieut, C.; Pradayrol, L.; Fourmy, D. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci., 2003, 24, 36-40.
18. Salom, D.; Lodowski, D.T.; Stenkamp, R.E.; Le Trong, I.; Golczak, M.; Jastrzebska, B.; Harris, T.; Ballesteros, J.A.; Palczewski, K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci., 2006, 103, 16123-16128.
19. Terrillon, S.; Durroux, T.; Mouillac, B.; Breit, A.; Ayoub, M.A.; Taulan, M.; Jockers, R.; Barberis, C.; Bouvier, M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo-and heterodimers during biosynthesis. Mol. Endocrinol., 2003, 17, 677-691.
20. Devost, D.; Zingg, H.H. Homo-and hetero-dimeric complex formations of the human oxytocin receptor. J. Neuroendocrinol., 2004, 16 372-377.
21. Barberis, C.; Tribollet, E. Vasopressin and oxytocin receptors in the central nervous system. Crit. Rev. Neurobiol., 1996, 10, 119-154.
22. Garcia-Sosa, A.T.; Mancera, R.L. The effect of tightly-bound water molecules on scaffold diversity in computer-aided de novo ligand design of CDK-2 inhibitors. J. Mol. Model., 2006, 12, 422-431.
23. Hénin, J.; Maigret, B.; Tarek, M.; Escrieut, C.; Fourmy, D.; Chi-pot, C. Probing a model of a GPCR/ligand complex in an explicit membrane environment. The human cholecystokinin-1 receptor. Biophys. J., 2006, 90, 1232-1240.
24. Gutiérrez-de-Teran, H.; Centeno, N.B.; Pastor, M.; Sanz, F. Novel approaches for modeling of the Al adenosine receptor and its agonist binding site. Proteins, 2004, 54, 705-715.
25. Schlegel, B.; Sippl, W.; Höltje, H-D. Molecular dynamics simulations of bovine rhodopsin: influence of protonation states and different membrane-mimicking environments. J. Mol. Model., 2005, 12, 49-64.
26. Röhrig, U.F.; Guidoni, L.; Rothlisberger, U. Early steps of the intramolecular signal transduction in rhodopsin explored by molecular dynamics simulations. Biochemistry, 2000, 41, 10799-10809.
27. Ota, T.; Furutani, Y.; Terakita, A.; Shichida, Y.; Kandori, H. Structural changes in the Schiff base region of squid rhodopsin upon photoisomerization studied by low-temperature FTIR spectroscopy. Biochemistry, 2006, 45, 2845-2851.
28. Okada, T.; Fujiyoshi, Y.; Silow, M.; Navarro, J.; Landau, E.M.; Shichida, Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci., 2002, 99, 5982-5987.
29. Ślusarz, M.J.; Ślusarz, R.; Ciarkowski, J. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin Via and oxytocin receptors-molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system. Biopolymers, 2006, 81, 321-338.
30. Ślusarz, M.J.; Ślusarz, R.; Kaźmierkiewicz, R.; Trojnar, J.; Wisniewski, K.; Ciarkowski, J. Molecular modeling of the neuro-hypophyseal receptor/atosiban complexes. Protein Pept. Lett., 2003, 10, 295-302.
31. Ślusarz, M.J.; Ślusarz, R.; Meadows, R.; Trojnar, J.; Ciarkowski, J. Molecular dynamics of complexes of atosiban with neurohypophy-seal receptors in the fully hydrated phospolipid bilayer. QSAR Comb. Sci., 2004, 23, 536-545.
32. Ślusarz, M.J.; Gieldón, A.; Ślusarz, R.; Meadows, R.; Trojnar, J.; Ciarkowski, J. Study of New Oxytocin Antagonist Barusiban Fe200 440, Affinity Toward Human Oxytocin Receptor Versus Vasopressin V1a and V2 Receptors-Molecular Dynamics Simulation in POPC Bilayer. QSAR Comb. Sci., 2005, 24, 603-610.
33. Ślusarz, M.J.; Ślusarz, R.; Ciarkowski, J. Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state. J. Pept. Sci., 2006, 12, 171-179.
34. Ślusarz, M.J.; Gieldoń, A.; Ślusarz, R.; Ciarkowski, J. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-Gα systems. J. Pept. Sci., 2006, 12, 180-189.
35. Ślusarz, M.J.; Sikorska, E.; Ślusarz, R.; Ciarkowski, J. Molecular docking-based study of vasopressin analogues modified at positions 2 and 3 with N-methylphenylalanine: influence on receptor-bound conformations and interactions with vasopressin and oxytocin receptors. J. Med. Chem., 2006, 49, 2463-2469.
36. Cieplak, P.; Cornell, W.D.; Bayly, C.; Kollman, P.A. Application of the Multimolecule and Multiconformational RESP Methodology to Biopolymers: Charge Derication for DNA, RNA, and Proteins. J. Comput. Chem. 1995, 16, 1357-1377.
37. Schmidt, M.W.; Baldridge, K.K.; Boatz, J.A.; Elbert, S.T.; Gordon, M.S.; Jensen, J.H.; Koseki, S.; Matsunaga, N.; Nguyen, K.A.; Su, S.; Windus, T.L.; Dupuis, M.; Montgomery, J. General Atomic and Molecular Electronic Structure System. J. Comput. Chem., 1993, 14, 1347-1363.
38. Sybyl 6.8, Tripos Inc. 1699 South Hanley Rd.; St. Louis, MO 63144, U.S.A.
39. Kirkpatrick, S.; Gelatt, C. D. Jr.; Vecchi, M. P. Optimization by simulated annealing. Science, 1983, 220, 671-680.
40. Case, D.A.; Pearlman, D.A.; Caldwell, J.W.; Cheatham, T.E.; Wang, J.; Ross, W.S.; Simmerling, C.L.; Darden, T.A.; Merz, K.M.; Stanton, R.V.; Cheng, A.; Vincent, J.J.; Crowley, M.; Tsui, V.; Gohlke, H.; Radmer, R.; Duan, Y.; Pitera, J.; Massova, I.; Seibel, G.L.; Singh, U.C.; Weiner, P.; Kollman, P.A. Amber 7. University of California, San Francisco, 2002.
41. Langs, D.A.; Smith, G.D.; Stezowski, J.J.; Hughes, R.E. Structure of pressinoic acid: the cyclic moiety of vasopressin. Science, 1986, 232, 1240-1242.
42. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. Automated docking using a La-marckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 1998, 19, 1639-1662.
43. Goodsell, D.S.; Morris, G.M.; Olson, A.J. Automated docking of flexible ligands: applications of AutoDock. J. Mol. Recognition, 1996, 9, 1-5.
44. Murzyn, K.; Róg, T.; Jezierski, G.; Takaoka, Y.; Pasenkiewicz-Gierula, M. Effects of phospholipid unsaturation on the membrane/water interface: a molecular simulation study. Biophys. J., 2001, 81, 170-183.
45. Pasenkiewicz-Gierula, M.; Murzyn, K.; Rog, T.; Czaplewski, C. Molecular dynamics simulation studies of lipid bilayer systems. Acta Biochim. Polon., 2000, 47, 601-611.
46. Essmann, U.L.; Perera, M.L.; Berkowitz, T.; Darden, T.; Lee, H.; Pedersen, L.G. A smooth particle mesh Ewald method. J. Chem. Phys., 1995, 103, 8577-8593.
47. Jorgensen, W.L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc., 1988, 770, 1657-1666.
48. Wang, J.; Cieplak, P.; Kollman, P.A. How well does a restrained electrostatic potential RESP, model perform in calcluating confor-mational energies of organic and biological molecules? J. Comput. Chem., 2000, 21, 1049-1074.
49. Bernstein, H.J. Recent changes to RasMol, recombining the variants. TIBS 2000, 2000, 25, 453-455.
50. Ballesteros, J.A.; Weinstein, H. Integrated Methods for Modeling G-Protein Coupled Receptors. Methods Neurosci., 1995, 25, 366-428.
51. Hubbell, W.L.; Altenbach, C.; Hubbell, C.M.; Khorana, H.G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide crosslinking. Adv. Protein Chem., 2003, 63, 243-290.
52. Fanelli, F.; Barbier, P.; Zanchetta, D.; De Benedetti, P.G.; Chini, B. Activation Mechanism of Human Oxytocin Receptor: A Combined Study of Experimental and Computer-Simulated Mutagenesis. Mol. Pharmacol., 1999, 56, 214-225.
53. Wheatley, M.; Hawtin, S.R.; Yarwood, N.J. Structure/function studies on receptors for vasopressin and oxytocin. Adv. Exp. Med. Biol., 1998, 449, 363-365.
54. Zhou, W.; Flanagan, C.; Ballesteros, J. A.; Konvicka, K.; Davidson, J. S.; Weinstein, H.; Millar, R.P.; Sealfon, S.C. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotro-pin-releasing hormone receptor. Mol. Pharmacol., 1994, 45, 165-170.
55. Sealfon, S.C; Chi, L.; Ebersole, B.J.; Rodic, V.; Zhang, D.; Ballesteros, J.A.; Weinstein, H. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J. Biol. Chem., 1995, 270, 16683-16688.
56. Hulme, E.C.; Lu, Z.L.; Saldanha, J.W.; Bee, M.S. Structure and activation of muscarinic acetylcholine receptors. Biochem. Soc. Trans., 2001, 31, 29-34.
57. Roche, J.P.; Bounds, S.; Brown, S.; Mackie, K. A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization. Mol. Pharmacol., 1999, 56, 611-618.